Molecular Neurodegeneration Course 2017 Cambridge, England, UK 9-14 January 2017

Description:
The programme will focus on several disorders including Alzheimer’s disease, Parkinson’s disease, Fragile X, Spinocerebellar ataxia and amyotrophic lateral sclerosis. There are many parallels between different neurodegenerative disorders and the course will examine the common themes across neurodegenerative processes. Participants will gain an insight into the current understanding of both rare and common neurological disorders, the strengths and weaknesses of experimental approaches and evidence, and how this knowledge can be applied to develop therapies.

The programme is aimed at individuals working in neurodegenerative research, neurogenetics or translational neuroscience, including clinician scientists, veterinary scientists, PhD students and post-doctoral researchers. We encourage applications from researchers based in the pharmaceutical and biotechnology industries. Applications from those who have completed a PhD in another area and have moved into neuroscience for their postdoctoral studies will also be considered.

Prices:
Academic registration with single accommodation: GBP 700
Commercial registration with single accommodation: GBP 1000

Speakers: Scientific programme committee: Sue Ackerman (University of California, San Francisco, USA), Mark Cookson (National Institutes of Health, USA), Beverly Davidson (The Children’s Hospital of Philadelphia, USA), Harry Orr (University of Minnesota, USA), Nicholas Wood (University College London, UK)

Time: 12:00 pm to 4:00 pm